Exelixis · 2 weeks ago
Senior Commercial Strategy & Planning Manager (New Product Planning)
Alameda, CA
Full-time
Onsite
Senior Level
$160K/yr - $227K/yr
5+ years expExelixis is a biopharmaceutical company focused on advancing its pipeline assets. The Senior Manager, Commercial Strategy and Planning will drive commercial analysis and strategic planning activities, particularly for the Antibody Drug Conjugate pipeline, and work cross-functionally to provide critical insights to leadership.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Primarily responsible for driving pipeline commercial analysis and strategic planning activities, with a focus on Exelixis’ growing Antibody Drug Conjugate (ADC) pipeline, with secondary responsibilities for supporting additional CSP activities
Work cross-functionally with Commercial, Clinical Development, Translational Medicine, Medical Affairs, Discovery, and Finance functions to generate defensible recommendations
Drive data and insight-driven commercial analyses and project approaches to support pipeline strategy in the context of the ADC Franchise Team (FT). Inform decision making for ADC programs through the product lifecycle (development candidate nomination through Phase 3), including: Develop and provide oncology treatment and competitive landscape expertise in key solid tumors to inform program development decisions
Support and drive cross-functional strategic planning activities including indication prioritization, combination planning, lifecycle management (LCM) and fast-to-market planning
Lead Target Product Profile (TPP) development and refinement
Provide commercial assessment of pipeline development opportunities, including market attractiveness, unmet need, and competitive dynamics
Plan and execute primary and secondary market research to support commercial opportunity assessment and revenue forecast assumptions, as needed
Develop patient-based revenue forecasts for potential indications to support business planning
Deep dive assessments of companies and relevant marketed products and pipeline, including revenue forecasts, company financial analyses, disease and competitive landscapes, and market access and pricing insights
Provide comprehensive competitive intelligence to inform pipeline strategy and competitive positioning: Monitor for competitor and disease landscape news, clinical developments, data releases, announcements, and other relevant disclosures
Generate alerts of key developments for stakeholders, including senior leadership
Attend relevant conferences and provide summaries of key presentations that contextualize data with clinical and scientific benchmarks
Secondary responsibilities for supporting additional Commercial Strategy & Planning activities, including: Commercial analysis to support the strategic development of Exelixis’ small molecule and immuno-oncology pipeline assets, as needed
Commercial due diligence and opportunity assessments to inform Business Development (BD) opportunities, as needed
Support portfolio strategy and BD analyses and activities
Determine the appropriate analyses required to answer key business questions and generate data driven recommendations
Provide and ensure the interpretation of complex analytical information to include Primary and Secondary Data, Forecasting, Competitive Intelligence, Scenario Planning, and other relevant sources of information and analysis
Develop and oversee execution of US and Global market research, including management of third parties
Presentation of key deliverables to a broad range of stakeholders, including senior leadership
Qualification
Required
BS/BA degree in related discipline and 5 years of related experience; or
Advanced degree (Master's and/or Ph.D) in related discipline and 3 years of related experience; or
Equivalent combination of education and experience
Previous new product evaluation experience required
Proficiency in scientific and clinical literature analysis, enabling quick assessment of clinical data and oncology markets
Strong foundation in patient-based forecasting and quantitative modeling methodologies
Experience with qualitative and quantitative primary research methods
Demonstrates strong collaboration skills and ability to be a strategic thought partner
Ability to navigate uncertainty and apply structured thinking and decision-making frameworks to complex business questions
Ability to influence without authority, and able to clearly represent the commercial perspective to Clinical Development, Discovery, Translational Medicine, and other functional partners
Ability to effectively balance multiple priorities under pressure; understands when to right-size, where appropriate
Effective presentation and communication skills, both verbal and written
Excellent organizational, project management and problem-solving skills
Preferred
Prior oncology experience highly desired with specialty product experience as a minimum
Previous experience in life sciences strategy consulting or pharma/biotech analytics is highly desirable
Previous experience in biopharma industry preferred
Benefits
401k plan with generous company contributions
Group medical, dental and vision coverage
Life and disability insurance
Flexible spending accounts
Discretionary annual bonus program
Sales-based incentive plan
Opportunity to purchase company stock
Receive long-term incentives
15 accrued vacation days in their first year
17 paid holidays including a company-wide winter shutdown in December
Up to 10 sick days throughout the calendar year
Company
Exelixis
Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.
1001-5000 employees
H1B Sponsorship
Exelixis has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (39)
2024 (25)
2023 (25)
2022 (28)
2021 (29)
2020 (15)
Funding
Current Stage
Public CompanyTotal Funding
$514MKey Investors
Deerfield
2015-07-23Post Ipo Equity· $135M
2012-02-16Post Ipo Equity· $65M
2010-06-03Post Ipo Debt· $160M
Leadership Team
Michael Morrissey
President and CEO
Christopher Senner
Executive Vice President and CFO
Recent News
The Motley Fool
2026-01-09
2026-01-08
Company data provided by crunchbase